Nebenwirkungen · Levetiracetam Sun
Levetiracetam SUN 100 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10
HOS-213387 · Präparat HOS-155098
In patients aged 1 month to less than 4 years, a total of 190 patients have been treated with levetiracetam in placebo-controlled and open label extension studies. Sixty of these patients were treated with levetiracetam in placebo-controlled studies. In patients aged 4-16 years, a total of 645 patients have been treated with levetiracetam in placebo-controlled and open label extension studies. 233 of these patients were treated with levetiracetam in placebo-controlled studies. In both these paediatric age ranges, these data are supplemented with the post-marketing experience of the use of levetiracetam.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-01-05T17:50:00Z · SHA-256 f80259f0a633129e975a9f79564d138649ec314b1edc442f788673298850b8fe · Passage fedc1a5f0e0c30ef1fe608375aff0dcee15b729856ff083e7adbddf0844db5ae · Zeichen 8855–9465 im Abschnitt